Photograph by: YVES HERMAN
Credit: REUTERS
As the world waits to see whether the tenofovir microbicide tested in
South Africa will block HIV infection – the results will be released in
July – marketing expert Paul McGowan from the agency Added Value spoke
about the role that marketing could play in promoting any successful
product.
He said that HIV prevention messages were struggling to get through in
South Africa since people had reached “saturation point” on HIV.
McGowan said a survey of modern young women found they were not
receptive to prevention messages and felt like they were not at risk of
the virus – in a country where an estimated 10% of the adult population
is HIV positive.
“They had the idea it won’t happen to me, they feel safe, the only
sleep with nice people ... it is still his decision and to challenge
him is to risk the relationship, they don’t talk about HIV and feel it
is better not to know than to shatter a dream,” said McGowan.
He said it would be necessary to create a desire for microbicides – to
turn them into a product that people cannot live without.
M2010 co-chairman Dr. Ian McGowan, from the University of Pittsburgh’s
Medical School, said the conference – in the city of 446 bridges - had
built bridges between different disciplines, between social
researchers, scientists and communities.
McGowan reviewed other highlights from the conference, including the role
of antiretroviral drugs in the development of new microbicides.
“We’re in the era of antiretrovirals, whether oral PrEP (pre-exposure
prophylaxis tablets to stop HIV), topical PrEP (microbicide gels or
rings to go into the vagina), their potency and questions on whether
there is going to be drug resistance,” he said at the closing ceremony.
Another issue that dominated the agenda was the high prevalence of HIV
among men having sex with men – including in Africa – and the neglect
of these men by HIV prevention efforts.
“This meeting more than any other has been open and honest about
sharing the needs of men who have sex with men, the frequency and
urgent need to move ahead in developing rectal microbicides,” McGowan
observed.